Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone

TOKYO, Feb 28, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that the company has entered into a license agreement granting the exclusive development and distribution rights for the fibroblast growth factor (FGF) receptor selective tyrosine […]

Mazda Production and Sales Results for January 2025

Mazda Motor Corporation’s production and sales results for January 2025 are summarized below. I. Production 1. Domestic Production Mazda’s domestic production volume in January 2025 increased 22.6% year on year due to increased production of passenger vehicles. [Domestic production of […]

Eisai Selected for “Human Capital Leaders 2024” and “Human Capital Management Gold Quality” for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives

TOKYO, Feb 20, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that it has been selected for “Human CapitalLeaders 2024” and “Human Capital Management Gold Quality” in the “Human Capital Survey 2024” jointly conducted by HR […]